Catalyst Wire Dossier Catalyst Wire Dossier

Bictegravir

bictegravir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Bictegravir, covering 2019-10-11 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE [Phase 4]

See pricing